Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? ; volume:41 ; number:5 ; day:27 ; month:3 ; year:2023 ; pages:1329-1335 ; date:5.2023
World journal of urology ; 41, Heft 5 (27.3.2023), 1329-1335, 5.2023
- Creator
-
Busetto, Gian Maria
Finati, Marco
Chirico, Marco
Cinelli, Francesco
D’Altilia, Nicola
Falagario, Ugo G.
Sanguedolce, Francesca
Giudice, Francesco Del
Berardinis, Ettore De
Ferro, Matteo
Crocetto, Felice
Porreca, Angelo
Gianfrancesco, Luca Di
Calo’, Beppe
Mancini, Vito
Bettocchi, Carlo
Carrieri, Giuseppe
Cormio, Luigi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00345-023-04372-5
- URN
-
urn:nbn:de:101:1-2023090813182844475698
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Busetto, Gian Maria
- Finati, Marco
- Chirico, Marco
- Cinelli, Francesco
- D’Altilia, Nicola
- Falagario, Ugo G.
- Sanguedolce, Francesca
- Giudice, Francesco Del
- Berardinis, Ettore De
- Ferro, Matteo
- Crocetto, Felice
- Porreca, Angelo
- Gianfrancesco, Luca Di
- Calo’, Beppe
- Mancini, Vito
- Bettocchi, Carlo
- Carrieri, Giuseppe
- Cormio, Luigi
- SpringerLink (Online service)
Other Objects (12)
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
B.C.G.-Schutzimpfung
B.C.G.-Schutzimpfung
BCG-Lupus
BCG-Schutzimpfung
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
Morphologische Reaktion und Komplikation nach BCG-Impfung: BCG-Osteomyelitis
BCG Tuberkulose-Schutzimpfung
BCG. Abgeworfener Reiter
Die BCG-Schutzimpfung
BCG BIG-G
BCG Schutzimpfung, Impfschäden
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
B.C.G.-Schutzimpfung
B.C.G.-Schutzimpfung
BCG-Lupus
BCG-Schutzimpfung
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
Morphologische Reaktion und Komplikation nach BCG-Impfung: BCG-Osteomyelitis
BCG Tuberkulose-Schutzimpfung
BCG. Abgeworfener Reiter
Die BCG-Schutzimpfung
BCG BIG-G
BCG Schutzimpfung, Impfschäden
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
B.C.G.-Schutzimpfung
B.C.G.-Schutzimpfung
BCG-Lupus
BCG-Schutzimpfung
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
Morphologische Reaktion und Komplikation nach BCG-Impfung: BCG-Osteomyelitis
BCG Tuberkulose-Schutzimpfung
BCG. Abgeworfener Reiter
Die BCG-Schutzimpfung
BCG BIG-G